Valneva SE (VALN) Times Interest Earned (2021 - 2026)
Valneva SE's (VALN) quarterly Times Interest Earned came in at -$5.44 in Q1 2026, up 34.21% year-on-year from -$4.06 in Q1 2025, and up 36.06% quarter-over-quarter from -$8.51 in Q4 2025.
Valneva SE (VALN) Times Interest Earned (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Times Interest Earned across 6 years of filings, most recently posting -$5.44 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$5.44, up 34.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.2 (down 59.86% YoY), and the FY2025 annual result was -$1.96, down 452.61% from the prior year.
- Times Interest Earned came in at -$5.44 for Q1 2026 at Valneva SE, up from -$8.51 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $37.92 in Q2 2022 to a low of -$27.69 in Q4 2024.
- The 5-year median for Times Interest Earned is -$4.94 (2024), against an average of -$3.21.
- Across the five-year window, Times Interest Earned soared 163.46% in 2022 and tumbled 551.08% in 2024, its largest moves.
- Valneva SE's Times Interest Earned stood at -$1.74 in 2022, then sank by 144.9% to -$4.25 in 2023, then sank by 551.08% to -$27.69 in 2024, then surged by 69.25% to -$8.51 in 2025, then soared by 36.06% to -$5.44 in 2026.
- The last three Times Interest Earned figures came in at -$5.44 (Q1 2026), -$8.51 (Q4 2025), and $1.46 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | -5.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.44 |
| Dec 31, 2025 | -8.51 |
| Sep 30, 2025 | 1.46 |
| Jun 30, 2025 | -8.18 |
| Mar 31, 2025 | -8.27 |
| Dec 31, 2024 | -27.69 |
| Sep 30, 2024 | 1.59 |
| Jun 30, 2024 | -8.37 |
| Mar 31, 2024 | -4.94 |
| Dec 31, 2023 | -4.25 |
| Sep 30, 2023 | -12.20 |
| Jun 30, 2023 | 4.86 |
| Mar 31, 2023 | 3.25 |
| Dec 31, 2022 | -1.74 |
| Sep 30, 2022 | -17.96 |
| Jun 30, 2022 | 37.92 |
| Mar 31, 2022 | 3.90 |
| Dec 31, 2021 | 6.06 |
| Sep 30, 2021 | 40.86 |
| Jun 30, 2021 | 14.39 |